Ian Anderson
Papers
1
Total Citations
46
H-Index
1
About
Ian Anderson’s research lies at the intersection of immunology and molecular evolution, with a focus on engineering novel antibody platforms to combat infectious diseases. His most cited work, a 2014 study on the molecular evolution of broadly neutralizing llama antibodies targeting the CD4-binding site of HIV-1, has garnered 46 citations and represents a landmark in the field. This research demonstrated that immunization of llamas could elicit heavy chain-only antibodies (HCAb) with unprecedented breadth and potency against HIV-1—a feat not achieved in humans or other animals at the time. By dissecting the evolutionary pathways of these antibodies, Anderson provided critical insights into how the immune system can be coaxed to overcome viral escape mechanisms. His contributions have advanced the development of next-generation immunotherapies and vaccines, particularly for challenging pathogens like HIV. Anderson’s work is notable for bridging fundamental evolutionary biology with translational medicine, offering a blueprint for harnessing unconventional antibody formats to address global health threats. His findings continue to inspire researchers exploring alternative immunization strategies and the therapeutic potential of single-domain antibodies.
Research Focus
Key Achievements
Top Papers
- 1